secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001193125-25-277598
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex Q3 revenue $12.5M (+8% YoY); expects positive adjusted EBITDA in FY2025
------------------------------------------------------------------------------

- Total revenue $12.5M (+8% YoY); Cyclo G6 revenue $3.5M (+13%); Retina revenue $6.7M (+4%).
- Gross margin 32.1% down 520 bps due to one-time $0.8M inventory write-down; operating expenses down 12%.
- Net loss $1.6M ($0.09 per share) vs $1.9M ($0.12) prior year; adjusted EBITDA loss improved to $0.1M from $1.4M.
- Cash $5.6M, down $1.2M in quarter; guidance: cash flow breakeven in Q4 and positive adjusted EBITDA for full year 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000119312525277598/0001193125-25-277598-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000119312525277598/irix-20251111.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-277598

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer